Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: BRADLEY PHARMACEUTICALS (BPRXA)

No earlier versions found for this Subject.

Return to BRADLEY PHARMACEUTICALS (BPRXA)

Bradley Pharmaceuticals, the 43rd fastest growing firm in the US in 1994, is anticipating new acquisitions and exciting developments. The firm manufactures a variety of products in the nutritional, personal hygiene, dermatological, respiratory, and internal medicine market segments. These products are marketed through its subsidiaries, KENWOOD LABORATORIES and DOAK DERMATOLOGICS, in over 25 countries. The address of the company is 383 Route 46 West, Fairfield, NJ 07004. The phone number is 201-882-1505. A good contact inside is Mike Ross with investor relations at extension 242. More to come...